2024-10-31 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis Report 

**Company Overview:** Colgate-Palmolive Co is a multinational consumer products company that manufactures and sells oral care, personal care, and home care products.

**1. Performance Comparison:**

* **Cumulative Return:** CL: 32.81%, VOO (S&P 500): 136.74%
* **Relative Performance:** The stock has underperformed the S&P 500 significantly, with a cumulative return difference of -103.93%. This places the stock at the 0th percentile relative to its historical performance against the S&P 500.

**2. Recent Price Movement:**

* **Closing Price:** $94.72 (Last Market: $94.84)
* **Moving Averages:** 5-Day: $96.96, 20-Day: $99.44, 60-Day: $102.65

The stock is currently trading below all three moving averages, indicating a potential downward trend. The price is near the last market price, suggesting limited recent volatility.

**3. Technical Indicators:**

* **RSI:** 26.39 -  The RSI indicates that the stock is in oversold territory, suggesting a potential bounce.
* **PPO:** -0.49 -  The PPO is negative, indicating a downtrend.
* **Delta_Previous_Relative_Divergence:** -9.8 - This indicates a short-term bearish trend. 
* **Expected Return:** 0.0% -  The expected return is 0%, suggesting that the stock is not expected to outperform the S&P 500 over a long-term investment period.

**4. Recent Earnings and Outlook:**

| Date       | EPS  | Revenue        |
|------------|------|-----------------|
| 2024-10-25 | 0.9  | $5.03B          |
| 2024-07-26 | 0.89 | $5.06B          |
| 2024-04-26 | 0.83 | $5.07B          |
| 2023-10-27 | 0.86 | $4.92B          |
| 2023-10-25 | 0.86 | $4.92B          |

Earnings have been consistently above $0.80 per share for the past few quarters, showing some stability in earnings performance. The latest earnings report was not available, so it's not possible to assess whether the reported earnings met or exceeded expectations. 

**5. Financial Information:**

**Revenue and Profitability**

| Quarter        | Revenue | Profit Margin |
|----------------|---------|---------------|
| 2024-09-30      | $5.03B  | 61.08%        |
| 2024-06-30      | $5.06B  | 60.62%        |
| 2024-03-31      | $5.07B  | 60.00%        |
| 2023-12-31      | $4.95B  | 59.60%        |
| 2023-09-30      | $4.92B  | 58.54%        |

**Capital and Profitability**

| Quarter        | Equity   | ROE         |
|----------------|----------|--------------|
| 2024-09-30      | $0.43B  | 169.43%      |
| 2024-06-30      | $0.12B  | 594.31%      |
| 2024-03-31      | $0.23B  | 296.96%      |
| 2023-12-31      | $0.61B  | 117.90%      |
| 2023-09-30      | $-0.01B | -7866.67%     |

The company has shown stable revenue growth over the last year, with consistently high profit margins.  ROE has fluctuated significantly, indicating a potential inconsistency in the effectiveness of capital usage. 

**6. News and Recent Issues:**

* **Recent Earnings News:** There is no specific information about the latest earnings report for Colgate-Palmolive available within the provided context. 
* **Recent Market Outlook:**  
   * **Analyst Opinions:**  Analyst sentiment on CL is mixed, with some analysts issuing buy ratings and others issuing hold or sell ratings. The average price target for CL is currently above the current trading price, indicating potential upside for the stock.
   * **Performance Highlights:**  The stock has underperformed the broader market in recent years. 
* **Finbold:** [link to relevant Finbold article if available]

**7. Overall Analysis:**

* Colgate-Palmolive has a solid track record of profitability and revenue growth. However, the stock is currently trading below key moving averages and has underperformed the market for a considerable period. 
* The company's recent earnings performance appears stable.
* The stock is currently in oversold territory, based on the RSI, which might present a buying opportunity for investors who believe in the company's long-term prospects.
* However, it's important to consider the potential risk of continued underperformance and monitor the company's financial performance and market trends closely.

**8. Investment Recommendation:**

Given the current market sentiment and technical indicators, Colgate-Palmolive (CL) is not recommended for a buy at this time. The stock is currently in a downward trend and has underperformed the market for an extended period.  However, if you have a long-term investment horizon and believe in the company's potential for growth, it might be worth considering a small position in your portfolio. 

Please conduct further research and consult with a financial advisor before making any investment decisions.

**Disclaimer:** This report is for informational purposes only and should not be considered financial advice.  
